BioCentury
ARTICLE | Financial News

Solstice secures $18 million in series A

January 5, 2013 12:35 AM UTC

New RNAi delivery company Solstice Biologics LLC (San Diego, Calif.) secured $18 million in a tranched series A round led by venBio. Aeris Capital is also participating. Solstice raised $3 million in the first tranche in November and $7.5 million in the second tranche in December. The remaining $7.5 million tranche is dependent on undisclosed milestones. ...